These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7516887)

  • 1. Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: comparison with normal blast cells.
    Tohyama K; Ueda T; Yoshida Y; Nakamura T
    Exp Hematol; 1994 Jul; 22(7):539-45. PubMed ID: 7516887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of myelodysplastic syndromes with cytokines].
    Tohyama K; Ueda T; Tsutani H; Wano Y; Nakamura T
    Rinsho Ketsueki; 1993 Mar; 34(3):277-82. PubMed ID: 8479078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
    Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
    Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors.
    Sawada K; Sato N; Tarumi T; Sakai N; Koizumi K; Sakurama S; Ieko M; Yasukouchi T; Koyanagawa Y; Yamaguchi M
    Br J Haematol; 1993 Mar; 83(3):349-58. PubMed ID: 7683482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: II. Response to combined colony-stimulating factors.
    Sawada K; Sato N; Notoya A; Tarumi T; Yasukouchi T; Yamaguchi M; Kohno M; Mikuni C; Koike T
    Eur J Haematol; 1995 Feb; 54(2):85-94. PubMed ID: 7535245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand.
    Strife A; Perez A; Lambek C; Wisniewski D; Bruno S; Darzynkiewicz Z; Clarkson B
    Cancer Res; 1993 Jan; 53(2):401-9. PubMed ID: 7678076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
    Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
    Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome.
    Xu H; Li A; Yu Y; Li J; Liu X; Wang X; Wang X; Xu G
    Int J Lab Hematol; 2009 Dec; 31(6):597-602. PubMed ID: 18637807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitional changes in immunophenotypic subpopulations of human peripheral blood CD34+ cells expanded in vitro.
    Koizumi K; Sawada K; Sato N; Hirayama S; Yasukouchi T; Yamaguchi M; Takahashi TA; Sekiguchi S; Koike T
    Exp Hematol; 1994 Nov; 22(12):1171-8. PubMed ID: 7523169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
    Gidáli J; Fehér I; Hollán SR
    Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes.
    Greenberg PL; Negrin R; Nagler A
    Cancer Surv; 1990; 9(1):199-212. PubMed ID: 2276114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro effects of hematopoietic growth factors on CD34+ cell from patients with myelodysplastic syndromes].
    Yang X; Gu X; Pei X; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):354-7. PubMed ID: 15624331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
    Chen G; Shao Z; Jia H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of GM-CSF for in vitro cytogenetic bone marrow analysis in patients with myelodysplastic syndrome].
    Karásková J; Holena O; Michalová K
    Cas Lek Cesk; 1997 Oct; 136(20):633-7. PubMed ID: 9490208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro growth and clinical response of leukemia cells to macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in acute leukemia].
    Takeyama H; Kajiguchi T; Miyata Y; Saito M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):873-8. PubMed ID: 10897214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
    Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cells.
    Rigolin GM; Porta MD; Ciccone M; Bugli AM; Bragotti LZ; Mauro E; Fraulini C; Rossi AR; Bardi A; Cuneo A; Castoldi G
    Br J Haematol; 2004 Aug; 126(4):501-7. PubMed ID: 15287942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.